FAKTOR OPTIONSSCHEIN - EVOTEC Share Price

Certificat

DE000UM4P9Z4

Market Closed - Deutsche Boerse AG 11:05:23 03/07/2024 pm IST
21.2 EUR +12.89% Intraday chart for FAKTOR OPTIONSSCHEIN - EVOTEC
Current month+16.04%
1 month-0.84%
Date Price Change
03/24/03 21.2 +12.89%
02/24/02 18.78 +3.30%
01/24/01 18.18 -0.49%
28/24/28 18.27 +16.59%
27/24/27 15.67 -7.61%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 11:05 pm IST

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying EVOTEC SE
Issuer UBS
WKN UM4P9Z
ISINDE000UM4P9Z4
Date issued 25/04/2024
Strike 6.133
Maturity Unlimited
Parity 0.14 : 1
Emission price 50
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 38.53
Lowest since issue 10.89
Spread 6
Spread %22.25%

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
9.545 EUR
Average target price
20.79 EUR
Spread / Average Target
+117.81%
Consensus